Work

Human RIG-I Antiviral Deficiency Caused by a Dominant-Negative Variant Trapped in a Signaling-Inactive State

Year: 2026
Type: preprint
Abstract: RIG-I is a cytosolic pattern-recognition receptor that detects viral RNA to initiate type I interferon responses. While gain-of-function helicase mutations cause human autoinflammatory disease, naturally occurring loss-of-function variants in conserved helicase motifs remain undescribed. Here, we identify a heterozygous G731R substitution in helicase motif VI in a patient with life-threatening COVID-19 pneumonia. Patient-derived immune cells exhibit severe defects in RIG-I-dependent antiviral signaling. Mechanistically, G731R is an intrinsic dominant-negative loss-of-function variant that retains high-affinity binding to viral RNA and ATP but lacks RNA-stimulated ATPase activity. Hydrogen-deuterium exchange mass spectrometry and stopped-flow kinetic analyses reveal that G731R fails to undergo the conformational transitions required for productive CARD exposure, trapping RIG-I in an RNA-bound, signaling-inactive CTD-mode intermediate that competitively inhibits wild-type RIG-I. In contrast, distinct substitutions at the same residue bidirectionally tune receptor activity, with bulky charged residues producing loss-of-function phenotypes and small hydrophobic residues producing gain-of-function phenotypes. Studies of this first naturally occurring dominant-negative RIG-I variant demonstrate that the conserved helicase motifs function as ATP-dependent conformational checkpoints that couple viral RNA recognition to productive antiviral signaling.
Language: English
Subfield: Immunology
Open Access status: green
OpenAlex ID: W7203758421
Cites:
Cited by:
Related to: 10